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A molecular neuroscientist with a pessimistic bent might feel that his field is coming to 
a close, seeing that most molecules contributing to a neuron’s well-being and functional 
states are now known to us. There will still be unexplored ion channels and transcrip-
tion factors in our genome, but isn’t it merely a matter of time before these will be 
dragged onto the experimental stage? His colleague with an optimistic outlook, exulting 
in the great possibilities that molecular tools put at our disposal, will see himself more at 
the dawn of molecular neuroscience. The realist takes his position somewhere between 
these two extremes, realizing that he faces major challenges if he desires to contribute 
meaningfully to neuroscience by continuing to explore the molecular terrain. I will list   
a few examples, of which I hasten to say that they represent my personal preference 
rather than what may be the most pressing priority within the molecular neuroscience 
community at large. 
The challenges begin with the grouping of proteins into functional complexes, as 
they operate in neural cells, preferably in vivo. We are well aware of the fact that most 
biological machines are assembled from sets of protein/transmembrane protein enti-
ties, but in only few instances are we able to reconstitute such a ‘machine’ from its 
parts with properties resembling those measured in vivo. A picture book example is 
the work on complexes of AMPA receptors and their auxiliary subunits, the TARPs, 
by the labs of R. Nicoll and D. Bredt, which demonstrated that the functional prop-
erties of AMPA receptors, as assessed by in vitro expression systems, required major 
modification to render them akin to those of postsynaptic AMPA channels. Such ter-
ritory remains uncharted for most transmitter receptors and voltage-gated ion chan-
nels. Jumping across the synaptic cleft, we are painfully aware that we are unable to 
reconstitute the players and events at the presynaptic fusion pore to account for the 
submillisecond transmitter release following an action potential. In many cases failure 
to reconstitute molecular machines with correct properties might reflect a missing con-
stituent. Hunting for the constituent is difficult and time consuming as anyone using 
genetic interaction screens can attest, whereas tagging the complex by genetic means, 
its isolation and analysis by modern mass spectroscopy provide promising alternative 
avenues. Naturally, the successful reconstitution of biological machines is prerequisite 
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to their structural elucidation, which will however take decades barring a quantum leap 
in determining the structure of membranous protein complexes.
The legion of cells that make up the brain can be classified according to numerous 
criteria. We commonly divide them in glial cells and neurons, and both of these major 
cell classes can be subdivided further. We expect a hippocampal CA1 pyramidal cell to 
differ from its presynaptic partner, a fast spiking parvalbumin-expressing GABAergic 
interneuron, in its gene expression and hence, the state of its chromatin, which ensures 
the appropriate transcriptional activity in this cell type. Knowledge of this ‘chromatin 
code’ for the many neural cell types, as well as of the dynamic range that the chroma-
tin state can undergo in response to diverse activity, is highly desirable but difficult 
to attain. Valiant attempts are underway to mark different cell types with fluorescent 
proteins by use of cell-type selective promoters, isolate these cells by laser dissection 
microscopy and obtain gene expression profiles from RNA. But I suspect that a more 
systematic communal large-scale approach will be required before we can define cell 
populations in the brain by their chromatin code. One beneficial corollary should be 
the knowledge of the plasticity of this code in health and disease. Another is the genetic 
access to the different cells by knowledge of which select genes or combinations thereof 
are expressed in them. This, in combination with recombinant viral vectors, should 
greatly advance the precise placement by genetic means of the increasing number of 
powerful molecular tools, of which optogenetic photostimulation, developed by K. 
Deisseroth in collaboration with G. Nagel and E. Bamberg, provides an elegant exam-
ple, by which we can inhibit or excite select neurons in the brain. We are furthermore 
in great need of temporal control of gene expression in select cell populations of the 
brain, permitting us to switch back and forth between expression states A and B for 
genes of interest, akin to the tet-on and -off systems introduced by M. Gossen and H. 
Bujard in 1992. This becomes a particularly pressing issue in the surging area of evalu-
ating links to behavior and cognition.
In conclusion, molecular approaches will continue by ingenious innovations to make 
inroads in neuroscience at the interface of physiology, cell biology and genetics. By its 
versatile nature, molecular biology ensures its contribution to our understanding of the 
workings of the brain. This is the good news! The bad news is that we need to wait to find 
out how. 
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